摘要
近年研究发现,内膜增生(IH)是引起人工血管移植内瘘功能丧失的重要原因之一。除应最大限度避免内皮损伤外,防治IH 主要方法还包括改良人工血管物理设计、药物防治、应用生物学技术以及近距放疗等。应用多种方法联合防治是未来的主要研究方向。
出处
《中国血液净化》
2009年第6期335-338,共4页
Chinese Journal of Blood Purification
参考文献27
-
1Ko PJ,Hsieh HC,Chu JJ,et al.Patency rates and complications of Exxcel yarn-wrrapped polytetrafluoroethylene grafts versus Gore-rex stretch polytetrafluoroethylene grafts:a prospective study[J].Surg Today,2004,34:409-412.
-
2Polo JR,Ligero JM,Diaz-Cartelle J,et al.Randomized comparison of 6-mm straight grafts versus 6-to 8-mm tapered grafts for brachial-axillary dialysis access[J].Vasc Surg,2004,40:319-324.
-
3Morice MC,Serruys PW,Barragan P,et al.Long-term clinical outcomes with sirolimus-eluting coronary stants:fiveyear results of the RAVEL trial[J].J Am Coll Cardiol,2007,2,50:1299-1304.
-
4Rotmans JI,Pattynama PM,Verhagen HJ,et al.Sirolimuseluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts:a 4-week follow-up study[J].Circulation,2005,111:1537-1542.
-
5Kafuza GL,Gershlick AH,Park SJ,et al.Comparison of neointimal formation in polymer-free paclitaxel stents versus stainless stents (from the ASPECT and ELUTES randomized clinical trials)[J].Am J Cardiol,2004,15,94:199-201.
-
6Masaki T,Rathi R,Zentner G,et al.Tahibition of neointimal hyperplajia in vascular grafes by sustained perivascular delivery of paclitaxel[J] Kidney Int,2004,66:2061-2069.
-
7Kohler TR,Toleikis PM,Gravett DM,et al.Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxeleluting mesh[J].J Yasc Surg,2007,45:1029-37,discussion 1037-1028.
-
8ElChoufani SE,Bolin P,Waien S,et al.Platelet adhesion testing may predict early hemodialysis arteriovenous graft and fistula failure in end-stage renal disease patients[J].Clin Appl Thromb Hemost,2008,14(4):399-409.
-
9Sreedhara R,Himmelfarb J,Lazarus JM,et al.Arti-platelet therapy ingraft throulbosis:results of a prospective,randomized,double-blind study[J].Kidney Int,1994,45:1477-83.
-
10Kuji T,Masaki T,Goteti K,et al.Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis[J].Kidney Int,2006,69:2179-2185.
同被引文献14
-
1钟伟强,杨铁城,余林权,刘冠贤.同种异体血管和人造血管移植制作动静脉内瘘的临床研究[J].中华显微外科杂志,2004,27(2):149-151. 被引量：18
-
2王玉柱.血液净化通路.北京:人民军医出版社,2009:65.
-
3Malek T,Alvarez -Ude F,Gil MT,et al. Changes in Vascular ac -cess in a dialysis unit in recent years: planning problems, Changein preferences, or demographic chang. Nefrologia, 2008,28 (5) :531 -538.
-
4Lafrance JP, Lqbal S, Lelorier J, et al. Vascular access - relat- edbloodstream infections in First Nations, community and teach- ingCanadian dialysis units, and other centre - level predictors. Nephron Clin Pratt,2010,114(3) :204 -212.
-
5王文娟,吴春燕,应迎娟,王国红,倪虹,莫华利,叶有新.穿刺方法对血透动静脉内瘘并发症的影响[J].中华护理杂志,2009,44(2):180-181. 被引量：171
-
6陆石.透析血管内瘘的术前评估及其内瘘成熟的判定[J].中国血液净化,2011,10(9):468-470. 被引量：10
-
7徐丽云,陈伟珍,蔡红芳.三维CT成像在尿毒症血管通路病变诊断及治疗中的应用[J].中国中西医结合肾病杂志,2012,13(1):59-60. 被引量：4
-
8张丽红,王玉柱.北美血管通路协会血液透析血管通路标准化定义解读[J].中国血液净化,2013,12(3):167-169. 被引量：35
-
9高民,汤日宁,杨金芳,张留平,王越,刘宏,涂岩,刘必成.肱动脉-贵要静脉内瘘与动静脉移植物内瘘在长期血液透析患者中的应用[J].中华医学杂志,2013,93(15):1150-1152. 被引量：7
-
10郑玉成.血液透析患者人工动静脉瘘的研究进展[J].青岛医药卫生,2013,45(4):288-289. 被引量：7
引证文献2
-
1徐丽云,林江英,杨超.自体静脉移植在动静脉内瘘手术中的应用[J].中国中西医结合肾病杂志,2013,14(1):66-67.
-
2吴瑶瑶,金领微,叶白如,陈冬蔚,谷禾.一体化血管通路团队管理对人工血管移植动静脉内瘘的作用[J].温州医科大学学报,2021,51(1):66-69. 被引量：2
-
1陈解语,龚智峰.耐药鲍曼不动杆菌感染的防治进展[J].中国临床新医学,2011,4(7):690-693. 被引量：6
-
2王临英,黄文祥.泛耐药鲍曼不动杆菌的防治进展[J].重庆医学,2010,39(20):2808-2811. 被引量：44
-
3张荣光,段广才.埃博拉病毒病的防治进展[J].新乡医学院学报,2014,31(11):865-871.
-
4王璇,杜蕊,韩悦,杨帆,汪春蕾.脂多糖的研究进展[J].黑龙江医药,2011,24(5):775-776. 被引量：10
-
5常继伟.移植物动脉粥样硬化与慢性排斥——机理及防治进展[J].国外医学（泌尿系统分册）,1997,17(2):74-76. 被引量：2
-
6王泓 ,贾文祥 .耐万古霉素肠球菌的实验室检测及防治进展[J].国外医学（临床生物化学与检验学分册）,2004,25(2):128-130. 被引量：3
-
7赵廷刚.水疗与电刺激联合防治大鼠失用性骨质疏松[J].中国组织工程研究与临床康复,2011,15(33):6115-6117. 被引量：2
-
8徐宗环,付玉生,吕家锐,高玉真.豫陕晋冀鲁5省布病联防工作及评价[J].中国地方病防治,1996,11(5):303-304. 被引量：3
-
9屈大坤,王耀平.小儿变态反应性疾病发病机制及防治进展[J].临床儿科杂志,2006,24(6):532-534. 被引量：4
-
10牛晓光,史伟云,谢立信.角膜移植术后免疫排斥反应的防治进展[J].中国实用眼科杂志,2003,21(4):245-248. 被引量：4
